[go: up one dir, main page]

AR029865A1 - Mezclas de polisacaridos sulfatados derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen - Google Patents

Mezclas de polisacaridos sulfatados derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen

Info

Publication number
AR029865A1
AR029865A1 ARP010103476A ARP010103476A AR029865A1 AR 029865 A1 AR029865 A1 AR 029865A1 AR P010103476 A ARP010103476 A AR P010103476A AR P010103476 A ARP010103476 A AR P010103476A AR 029865 A1 AR029865 A1 AR 029865A1
Authority
AR
Argentina
Prior art keywords
mixtures
activity
pharmaceutical compositions
compositions containing
derived
Prior art date
Application number
ARP010103476A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852768&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR029865(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR029865A1 publication Critical patent/AR029865A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Se refiere a las mezclas de polisacáridos sulfatados derivados de heparina, que tienen las siguientes características: tienen un peso molecular medio de 1500 a 3000 daltons, una actividad anti-Xa de 100 a 150 Ul/mg, una actividad anti-lla de 0 a 10 Ul/mg y una relacion actividad anti-Xa / actividad anti-lla superior a 10, los polisacáridos constitutivos de las mezclas contienen 2 a 26 disposiciones sacáridicas y tienen una disposicion ácido glucuronico - 4,5 insaturado 2 -O- sulfato en uno de sus extremos, bajo forma de una sal de metal alcalino o alcalinotérreo. También se describe el procedimiento de preparacion de dichas mezclas y las composiciones farmacéuticas que las contienen. Las mezclas presentan una actividad más selectiva frente a los factores X y II activadas (factor Xa y factor IIa).
ARP010103476A 2000-07-21 2001-07-20 Mezclas de polisacaridos sulfatados derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen AR029865A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0009572A FR2811992B1 (fr) 2000-07-21 2000-07-21 Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
AR029865A1 true AR029865A1 (es) 2003-07-16

Family

ID=8852768

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103476A AR029865A1 (es) 2000-07-21 2001-07-20 Mezclas de polisacaridos sulfatados derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen

Country Status (35)

Country Link
EP (1) EP1307491B2 (es)
JP (1) JP5279160B2 (es)
KR (1) KR100853585B1 (es)
CN (1) CN1230449C (es)
AP (1) AP1703A (es)
AR (1) AR029865A1 (es)
AT (1) ATE470679T1 (es)
AU (2) AU2001277602B2 (es)
BR (1) BR0112612B1 (es)
CA (1) CA2416673C (es)
CL (1) CL2004001154A1 (es)
CY (1) CY1110774T1 (es)
DE (1) DE60142340D1 (es)
DK (1) DK1307491T3 (es)
DZ (1) DZ3411A1 (es)
EA (1) EA005995B1 (es)
EC (1) ECSP034442A (es)
ES (1) ES2347134T5 (es)
FR (1) FR2811992B1 (es)
HR (1) HRP20030019A2 (es)
HU (1) HUP0300755A3 (es)
IL (2) IL153922A0 (es)
MA (1) MA26928A1 (es)
MX (1) MXPA03000579A (es)
NO (1) NO20030296L (es)
NZ (1) NZ524028A (es)
OA (1) OA12340A (es)
PL (1) PL202471B1 (es)
PT (1) PT1307491E (es)
SI (1) SI1307491T1 (es)
TW (1) TWI307278B (es)
UA (1) UA74836C2 (es)
WO (1) WO2002008295A1 (es)
YU (1) YU2903A (es)
ZA (1) ZA200300898B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6969705B2 (en) 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
EP1375524B1 (en) * 2002-06-20 2007-03-07 CHEMI S.p.A. Process for the preparation of esters of heparin
FR2845686B1 (fr) * 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
AR041555A1 (es) 2002-10-10 2005-05-18 Aventis Pharma Sa Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2857971B1 (fr) * 2003-07-24 2005-08-26 Aventis Pharma Sa Melanges d'oligosaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US7956046B2 (en) * 2003-07-24 2011-06-07 Aventis Pharma S.A. Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
DE102004059134B4 (de) 2004-12-08 2011-12-15 Siemens Ag Expansionsvorrichtung für ein Röntgengerät und Röntgenstrahler
FR2889078B1 (fr) * 2005-07-27 2007-11-02 Aventis Pharma Sa Nouvelle methode de chromatographie d'affinite d'antithrombine iii
CA2652205A1 (en) * 2006-05-25 2007-12-06 Mallik Sundaram Low molecular weight heparin composition and uses thereof
CN101824099B (zh) * 2010-02-12 2011-11-30 淮安麦德森化学有限公司 一种粗品肝素钠的纯化方法
CN101824446B (zh) * 2010-02-24 2012-12-12 淮安麦德森化学有限公司 反向沉淀生产硫酸软骨素的方法
EP2399591A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery
EP2399592A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in hip replacement surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2399590A1 (en) 2010-06-25 2011-12-28 Aventis Pharma S.A. Semuloparin for the prevention of a mortality and/or morbidity event in a patient undergoing major orthopaedic surgery
EP2399593A1 (en) 2010-06-28 2011-12-28 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile
CN102399379B (zh) * 2010-09-09 2016-08-31 上海喜恩医药科技发展有限公司 一种肝素衍生的多糖混合物及其制备方法和药物组合物
CN103209997B (zh) * 2010-09-14 2016-03-16 国立大学法人宫崎大学 高纯度肝素及其制备方法
WO2012055843A1 (en) 2010-10-28 2012-05-03 Aventis Pharma S.A. Semuloparin for the prevention of major venous thromboembolism in a patient undergoing major abdominal surgery
EP2446891A1 (en) 2010-10-28 2012-05-02 Aventis Pharma S.A. Semuloparin for use as an antithrombotic treatment in major abdominal surgery with improved safety in terms of clinically relevant bleedings and major bleedings
EP2548561A1 (en) 2011-07-22 2013-01-23 Aventis Pharma S.A. Semuloparin for improving the survival of patients with locally advanced cancer
ES2445494B1 (es) * 2012-08-02 2015-03-06 Rovi Lab Farmaceut Sa Procedimiento de obtención de heparinas de bajo y muy bajo peso molecular
CN103175925B (zh) * 2013-03-20 2014-12-03 山东辰中生物制药有限公司 依诺肝素钠生产过程中肝素苄基酯的酯化率的检测方法
FR3016632A1 (fr) * 2014-01-21 2015-07-24 IFP Energies Nouvelles Procede de transformation de polysaccharides en molecules oxygenees en presence de superbases organiques neutres
CZ306662B6 (cs) * 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
FR2482611B1 (fr) * 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
ES2077533B1 (es) * 1994-02-28 1996-07-01 Bioiberica Procedimiento de obtencion de fracciones de oligosacaridos por despolimerizacion quimica de heparina.
ES2161615B1 (es) * 1999-07-23 2003-03-16 Rovi Lab Farmaceut Sa Composiciones de heparinas de muy bajo peso molecular.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物

Also Published As

Publication number Publication date
JP2004504451A (ja) 2004-02-12
BR0112612A (pt) 2003-07-29
NO20030296D0 (no) 2003-01-20
EA005995B1 (ru) 2005-08-25
CN1447820A (zh) 2003-10-08
PL365561A1 (en) 2005-01-10
SI1307491T1 (sl) 2010-10-29
CA2416673C (fr) 2011-06-14
KR20030040364A (ko) 2003-05-22
PT1307491E (pt) 2010-09-10
DE60142340D1 (de) 2010-07-22
FR2811992A1 (fr) 2002-01-25
EP1307491B1 (fr) 2010-06-09
DK1307491T3 (da) 2010-10-11
IL153922A (en) 2010-05-17
TWI307278B (en) 2009-03-11
IL153922A0 (en) 2003-07-31
NZ524028A (en) 2004-12-24
MXPA03000579A (es) 2003-06-06
HUP0300755A3 (en) 2004-03-01
CY1110774T1 (el) 2015-06-10
HRP20030019A2 (en) 2005-10-31
AP2003002744A0 (en) 2003-03-31
HK1059273A1 (en) 2004-06-25
HUP0300755A2 (hu) 2003-12-29
YU2903A (sh) 2006-03-03
EA200300178A1 (ru) 2003-06-26
DZ3411A1 (fr) 2002-01-31
JP5279160B2 (ja) 2013-09-04
MA26928A1 (fr) 2004-12-20
FR2811992B1 (fr) 2003-07-04
ES2347134T3 (es) 2010-10-26
KR100853585B1 (ko) 2008-08-21
WO2002008295A1 (fr) 2002-01-31
ATE470679T1 (de) 2010-06-15
ECSP034442A (es) 2003-03-10
CA2416673A1 (fr) 2002-01-31
NO20030296L (no) 2003-01-20
UA74836C2 (en) 2006-02-15
CN1230449C (zh) 2005-12-07
ES2347134T5 (es) 2014-06-24
EP1307491B2 (fr) 2014-05-07
OA12340A (fr) 2006-05-15
ZA200300898B (en) 2004-04-30
PL202471B1 (pl) 2009-06-30
CL2004001154A1 (es) 2005-05-27
AU7760201A (en) 2002-02-05
AP1703A (en) 2007-02-26
BR0112612B1 (pt) 2011-07-12
EP1307491A1 (fr) 2003-05-07
AU2001277602B2 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
AR029865A1 (es) Mezclas de polisacaridos sulfatados derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen
CY1112808T1 (el) Μειγματα ολιγοσακχαριτων προερχομενων απο την ηπαρινη, η παρασκευη τους και φαρμακευτικες συνθεσεις που τα περιεχουν
IT1248557B (it) Miscele di polisaccaridi di bassi pesi molecolari, procedimento di preparazione e impiego.
AR040589A2 (es) Composiciones de copolimeros de injerto
ES2161615A1 (es) Composiciones de heparinas de muy bajo peso molecular.
DK0975235T3 (da) Ernæringssammensætninger indeholdende oligosaccharider
BR0001504A (pt) Plástisóis de poliaquil metacrilato com propriedades de escoamento aperfeiçoadas
DE69103833D1 (de) Biologisch abbaubares gepfropftes Polysaccharid enthaltende Waschmittelzusammensetzung.
NZ334021A (en) Dietary supplement containing at least two saccharides being the building blocks of glycoproteins
HRP20000008B1 (hr) Sastav mineralne vune sa svojstvom biorazgradivosti
AR018536A1 (es) Nuevos copolimeros tensioactivos a base de metilidenmalonato y la utilizacion de los mismos.
NZ333721A (en) Pharmaceutically acceptable synthetic polysaccharides
AR018142A1 (es) Composicion para el cabello que tiene un ph superior a 10 y comprende uno o mas derivados cationicos de goma guar
BR0000554A (pt) Sistema de caixa
AR045917A1 (es) Mezclas de oligosacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen
ES2100957T3 (es) Composiciones detergentes.
HRP20030430B1 (hr) Makrolidni solvati
BR0010381A (pt) Método de tratamento da trombose em um mamìfero, e uso de uma combinação de (i) um inibidor do fator xa, e (ii) um composto selecionado do grupo que consiste em aspirina, tpa, um antagonista gpiib/iiia, heparina de baixo peso molecular e heparina
DK0904299T3 (da) Syntetiske polysaccharider, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende sådanne polysaccharider
ES2162452T3 (es) Mejorador de la detergencia soluble en agua y ablandador del agua.
MX9400936A (es) Composicion de hidrolizado de fecula y metodo para su preparacion.
AR065328A1 (es) Heparinas que comprenden por lo menos un enlace covalente con la biotina o un derivado de la biotina , su procedimiento de preparacion y su utilizacion
TW200704403A (en) Dilution resistant viscoelastic compositions
NO974442L (no) Klebemiddelblanding inneholdende vannglass, et oligosakkarid, og et mono-, di- eller trisakkarid
AR041555A1 (es) Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen

Legal Events

Date Code Title Description
FG Grant, registration